Key Highlights
- Tradr 2X Short IREN Daily ETF (CBOE:IREZ) rose 16.84% to USD 21.72 on October 22, 2026, from USD 18.59, implying IREN fell about 8.4%, simple arithmetic on the published change and the quote.
- The day before, the fund fell 9.49%, so the October 22 gain follows a sharp rebound in the underlying, a typical whipsaw for daily-reset funds. The latest results missed Revenue estimates.
- IREN says its fiscal 2026 target of USD 4 billion of annualized Recurring Revenue is fully contracted, but fiscal 2027 Capital spending is projected at USD 25 billion to USD 30 billion.
- The shares were down about 22% for 2026 as of October 16, 2026, and Morningstar cut its price target to USD 37 from USD 43, reflecting higher borrowing costs for neoclouds.
What Moved the Fund
The fund rose 16.84% in the October 22, 2026 session after falling 9.49% on October 21, when IREN rose. The latest gain implies IREN fell about 8.4%. The trigger was a broad AI and semiconductor selloff plus fresh worries about neocloud financing. Lam Research (NASDAQ:LRCX) posted record revenue of USD 8.22 billion on October 21, 2026, then fell about 9% on October 22 after guiding December-quarter revenue to USD 8.6 billion, plus or minus USD 400 million, and citing Supply constraints. IREN had traded near USD 29.30 on October 16 and then USD 27.84, and it proposed a second Australian campus, Redbank, in preliminary planning with no secured grid connection or financing.
IREN Fundamentals
IREN (NASDAQ:IREN) reported fiscal fourth-quarter results in late August 2026. Revenue was USD 137.2 million against USD 157.14 million expected, and adjusted EBITDA was USD 19.2 million against USD 34.9 million. AI cloud revenue was USD 70.5 million, up 110% sequentially. Annualized recurring revenue was about USD 500 million at quarter end and about USD 1 billion after Microsoft accepted Horizon 1. The company reports USD 6.5 billion of GPU financing over three months, a multi-year deal with a frontier AI lab, and recent contract pricing above USD 20 million per megawatt a year. Wall Street expects fiscal 2027 revenue growth of about 117%, and H.C. Wainwright and Citizens rate the shares Buy and Market Outperform.
Mechanics and Risks
IREZ launched on January 21, 2026, trades on Cboe BZX, charges 1.49% and held about USD 14.5 million in assets. It seeks minus 2x of IREN's daily return and resets daily. If IREN rose 12% then fell 12%, the stock would end down 1.44% while the fund would end down 5.76%, simple arithmetic. New customer contracts, financing announcements or a recovery in neocloud Credit would lift IREN and hurt the fund. A one-day gain above 50% would erase it. The next IREN results date has not been confirmed. Swap financing costs add to the stated fee, and daily Rebalancing can create tracking gaps in violent sessions. A second Australian campus, Redbank, is only in preliminary planning, so expansion timelines are uncertain.
Where Things Stand
Tradr 2X Short IREN Daily ETF (CBOE:IREZ) surged because IREN fell about 8.4% as AI selloff and neocloud financing concerns hit the group, and the fund doubles the inverse. IREN's commercial momentum is real, with contracted ARR and Microsoft revenue, but missing revenue estimates, heavy capital spending and higher borrowing costs weigh on the stock. The next markers are contract and financing news and the fiscal first-quarter report, whose date is unconfirmed.






Please wait processing your request...